Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
Open Access
- 20 June 2013
- journal article
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 23 (9), 1422-1433
- https://doi.org/10.1101/gr.154492.113
Abstract
Hepatocellular carcinoma (HCC) is one of the most deadly cancers worldwide and has no effective treatment, yet the molecular basis of hepatocarcinogenesis remains largely unknown. Here we report findings from a whole-genome sequencing (WGS) study of 88 matched HCC tumor/normal pairs, 81 of which are Hepatitis B virus (HBV) positive, seeking to identify genetically altered genes and pathways implicated in HBV-associated HCC. We find beta-catenin to be the most frequently mutated oncogene (15.9%) and TP53 the most frequently mutated tumor suppressor (35.2%). The Wnt/beta-catenin and JAK/STAT pathways, altered in 62.5% and 45.5% of cases, respectively, are likely to act as two major oncogenic drivers in HCC. This study also identifies several prevalent and potentially actionable mutations, including activating mutations of Janus kinase 1 (JAK1), in 9.1% of patients and provides a path toward therapeutic intervention of the disease.Keywords
This publication has 68 references indexed in Scilit:
- Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor typesHuman Mutation, 2011
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic ScreeningCancer Cell, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- NF-κB and STAT3 – key players in liver inflammation and cancerCell Research, 2010
- Cancer gene discovery in hepatocellular carcinomaJournal of Hepatology, 2010
- Liver stem cells and hepatocellular carcinomaJournal of Hepatology, 2008
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Patterns of somatic mutation in human cancer genomesNature, 2007
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006